Kiedrowski MR, Bomberger JM. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract. Frontiers in Immunology [Internet]. 2018 [cited 2022 Oct 13];9. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2018.03067.

Crull MR, Somayaji R, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, et al. Changing rates of chronic pseudomonas aeruginosa infections in cystic fibrosis: a population-based cohort study. Clin Infect Dis. 2018;67:1089–95.

Article  PubMed  PubMed Central  Google Scholar 

Acosta N, Waddell B, Heirali A, Somayaji R, Surette MG, Workentine ML, et al. Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities. Frontiers in Cellular and Infection Microbiology [Internet]. 2020 [cited 2022 Oct 13];10. Available from: https://www.frontiersin.org/articles/10.3389/fcimb.2020.00173.

Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37:177–92.

Article  CAS  PubMed  Google Scholar 

Yu S, Pu X, Ahmed MU, Yu HH, Mutukuri TT, Li J, et al. Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa. Int J Pharm. 2021;610:121160.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allobawi R, Ghelani DP, Schneider-Futschik EK. Metabolomic description of Ivacaftor Elevating Polymyxin B mediated antibacterial activity in cystic fibrosis Pseudomonas aeruginosa. ACS Pharmacol Transl Sci. 2020;3:433–43 (American Chemical Society).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scavone C, Mascolo A, Ruggiero R, Sportiello L, Rafaniello C, Berrino L, et al. Quinolones-induced musculoskeletal, neurological, and psychiatric ADRs: a pharmacovigilance study based on data from the Italian spontaneous reporting system. Front Pharmacol. 2020;11:428.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhajj N, O’Reilly NJ, Cathcart H. Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection. Int J Pharm. 2022;613:121388.

Article  CAS  PubMed  Google Scholar 

Flume PA, O’Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines. Am J Respir Crit Care Med. 2007;176:957–69 (American Thoracic Society - AJRCCM).

Article  CAS  PubMed  Google Scholar 

Shetty N, Cipolla D, Park H, Zhou QT. Physical stability of dry powder inhaler formulations. Expert Opin Drug Deliv. 2020;17:77–96 (Taylor & Francis).

Article  CAS  PubMed  Google Scholar 

Levine H, Cohen-Cymberknoh M, Klein N, Hoshen M, Mussaffi H, Stafler P, et al. Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma. J Cyst Fibros. 2016;15:652–9.

Article  PubMed  Google Scholar 

Nangare S, Dugam S, Patil P, Tade R, Jadhav N. Silk industry waste protein: isolation, purification and fabrication of electrospun silk protein nanofibers as a possible nanocarrier for floating drug delivery. Nanotechnology. 2020;32:035101 (IOP Publishing).

Article  Google Scholar 

Radivojev S, Luschin-Ebengreuth G, Pinto JT, Laggner P, Cavecchi A, Cesari N, et al. Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance. Int J Pharm. 2021;606:120893.

Article  CAS  PubMed  Google Scholar 

Herrera LC, Tesoriero MV, Hermida LG. In vitro release testing of PLGA microspheres with Franz diffusion cells. Dissolution Technol. 2012;19:6–11.

Article  CAS  Google Scholar 

Bruschi ML, editor. 5 - Mathematical models of drug release. Strategies to Modify the Drug Release from Pharmaceutical Systems [Internet]. Woodhead Publishing; 2015 [cited 2022 Jul 27]. p. 63–86. Available from: https://www.sciencedirect.com/science/article/pii/B9780081000922000059. Accessed Sept 2022.

Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3:163–75.

Article  CAS  PubMed  Google Scholar 

Wijesinghe G, Dilhari A, Gayani B, Kottegoda N, Samaranayake L, Weerasekera M. Influence of Laboratory culture media on in vitro growth, adhesion, and biofilm formation of Pseudomonas aeruginosa and Staphylococcus aureus. MPP. 2019;28:28–35 (Karger Publishers).

Google Scholar 

Li W, Zhou J, Xu Y. Study of the in vitro cytotoxicity testing of medical devices (Review). Biomed Rep. 2015;3:617–20 (Spandidos Publications).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chai G, Park H, Yu S, Zhou F, Li J, Xu Q, et al. Evaluation of Co-delivery of Colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model. Int J Pharm. 2019;569:118616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Lei Y, Sui H, Zhang W, Zhu R, Feng J, et al. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid. Artif Cells Nanomed Biotechnol. 2017;45:740–7.

Article  CAS  PubMed  Google Scholar 

Mangal S, Meiser F, Tan G, Gengenbach T, Denman J, Rowles MR, et al. Relationship between surface concentration of l-leucine and bulk powder properties in spray dried formulations. Eur J Pharm Biopharm. 2015;94:160–9.

Article  CAS  PubMed  Google Scholar 

Thiyagarajan D, Huck B, Nothdurft B, Koch M, Rudolph D, Rutschmann M, et al. Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals. Drug Deliv Transl Res. 2021;11:1766–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg C-O, et al. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles. Int J Pharm. 2022;621:121758.

Article  CAS  PubMed  Google Scholar 

Momin MAM, Rangnekar B, Sinha S, Cheung C-Y, Cook GM, Das SC. Inhalable dry powder of Bedaquiline for pulmonary tuberculosis: in vitro physicochemical characterization, antimicrobial activity and safety studies. Pharmaceutics. 2019;11:502 (Multidisciplinary Digital Publishing Institute).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu P, Xing Y, Peng H, Liu Z, Zhou Q (Tony), Xue Z, et al. Physicochemical and Pharmacokinetic Evaluation of Spray-Dried Coformulation of Salvia miltiorrhiza Polyphenolic Acid and L-Leucine with Improved Bioavailability. J Aerosol Med Pulm Drug Deliv. Mary Ann Liebert, Inc., publishers; 2020;33:73–82.

Baysan U, ZungurBastıoğlu A, Coşkun NÖ, KonukTakma D, ÜlkeryıldızBalçık E, Sahin-Nadeem H, et al. The effect of coating material combination and encapsulation method on propolis powder properties. Powder Technol. 2021;384:332–41.

Article  CAS  Google Scholar 

Guo Y, Baldelli A, Singh A, Fathordoobady F, Kitts D, Pratap-Singh A. Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques. Sci Rep. 2022;12:9949 (Nature Publishing Group).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugandhi VV, Mahajan HS. Development of vitamin B12 containing pullulan-bovine serum albumin microparticles designed dry powder inhaler: In-vitro and in-vivo study. J Drug Deliv Sci Technol. 2022;70:103212.

Article  CAS  Google Scholar 

Clogston JD, Patri AK. Zeta potential measurement. Methods Mol Biol. 2011;697:63–70.

Article  CAS  PubMed  Google Scholar 

Tarhini M, Pizzoccaro A, Benlyamani I, Rebaud C, Greige-Gerges H, Fessi H, et al. Human serum albumin nanoparticles as nanovector carriers for proteins: Application to the antibacterial proteins “neutrophil elastase” and “secretory leukocyte protease inhibitor.” Int J Pharm. 2020;579:119150.

Article  CAS  PubMed  Google Scholar 

Edsman K, Hägerström H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol. 2005;57:3–22.

Article  CAS  PubMed  Google Scholar 

Scherließ R, Bock S, Bungert N, Neustock A, Valentin L. Particle engineering in dry powders for inhalation. Eur J Pharm Sci. 2022;172:106158.

Article  PubMed  Google Scholar